Advice
following a full submission:
ciclosporin 1mg/mL (0.1%) eye drops emulsion (Verkazia®) is accepted for use within NHSScotland.
Indication under review: treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents.
Ciclosporin eye drops compared with vehicle improved the signs and symptoms associated with VKC, as measured by improvements in keratitis, requirement for rescue medication and development of corneal ulcers.
Medicine details
- Medicine name:
- ciclosporin (Verkazia)
- SMC ID:
- SMC2111
- Indication:
- treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents (until the age of 18)
- Pharmaceutical company
- Santen
- BNF chapter
- Eye
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 10 December 2018